Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study.
Journal: Expert opinion on biological therapy
Published: December 15, 2020
An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12.
Journal: The British journal of dermatology
Published: September 18, 2019
Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study.
Journal: Journal of the American Academy of Dermatology
Published: June 03, 2019
Pigmented Bowen disease in a black patient: novel dermoscopic findings.
Journal: Cutis
Published: June 18, 2013
Excimer laser in the treatment of mycosis fungoides.
Journal: Journal of the American Academy of Dermatology
Published: May 22, 2013
Showing 1-5 of 5
Last Updated: 09/26/2026